A prospective, multicenter, randomized, placebo-controlled trial of physiologic testosterone supplementation for HIV-positive men with mildly to moderately reduced serum testosterone levels and abdominal obesity
Phase of Trial: Phase IV
Latest Information Update: 18 May 2012
At a glance
- Drugs Testosterone (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 03 Apr 2012 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 12 Oct 2005 New trial record.